/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Bluejay Diagnostics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.16 -0.0339(-3.39%) BJDX at 04 Dec 2025 04:27 PM Medical Devices
Lowest Today 1.13
Highest Today 1.2
Today’s Open 1.2
Prev. Close 1.18
52 Week High 10.20
52 Week Low 1.13
Day’s Range: Low 1.13 High 1.2
52-Week Range: Low 1.13 High 10.20
1 day return -
1 Week return -9.23
1 month return -25.55
3 month return -15.71
6 month return -21.33
1 year return -67.93
3 year return -98.81
5 year return -
10 year return -

Institutional Holdings

Sabby Management LLC 6.43

Fidelity Extended Market Index 0.23

Tower Research Capital LLC 0.15

Fidelity Series Total Market Index 0.05

UBS Group AG 0.03

Citigroup Inc 0.02

Bank of America Corp 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

SBI Securities Co Ltd 0.00

Market Status

Fundamentals

Market Cap 2.14 M

PB Ratio 0.6141

PE Ratio 0.0076

Enterprise Value -0.67 M

Total Assets 6.66 M

Volume 78361

Company Financials

Annual Revenue FY23:0 0.0M, FY22:249040 0.2M, FY21:75 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:0 0.0M, FY22:48911 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-10037400 -10.0M, FY22:-9227889 -9.2M, FY21:-3729686 -3.7M, FY20:-1125716 -1.1M, FY19:-757716 -0.8M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:216086 0.2M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-38355 -0.0M, Q1/2025:-51893 -0.1M, Q3/2024:null 0.0M, Q2/2024:-53717 -0.1M

Quarterly Net worth Q3/2025:-1597632 -1.6M, Q2/2025:-1956604 -2.0M, Q1/2025:-1864435 -1.9M, Q3/2024:-1481959 -1.5M, Q2/2024:-2475380 -2.5M

Fund house & investment objective

Company Information Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Organisation Medical Devices

Employees 7

Industry Medical Devices

CEO Mr. Indranil Dey

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow